Bernard Charra
Research Subjects
Research Interests
Bernard Charra has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
G Laurent
10 shared publicationsC Chazot
8 shared publicationsCharles Chazot
Center de Rein Artificiel, Tassin, France
8 shared publicationsT Vanel
8 shared publicationsThierry Vanel
Center de Rein Artificiel, Tassin, France
8 shared publicationsGuillaume Jean
Center de Rein Artificiel, Tassin, France
7 shared publications
Latest Publications
- 1 October 2007
- Published by JLE in Nephrologie & Therapeutique
- Vol. 3, S162-S169
L’hypertension affecte-t-elle ou non la survie des patients hémodialysés ?
Hypertension is very common in standard haemodialysis patients in spite of a wide use of antihypertensive medications. Up to the last decade it was reported in dialysis nts, as in the general population, as a powerful mortality risk factor. More recently several reports have challenged this view, and hypotension rather than hypertension has been claimed as the real culprit. That a risk factor has an opposite effect on mortality in conditions such as dialysis than in the general population has been termed - reverse epidemiology ,,, and suggests that our therapeutic approach toward blood pressure control in dialysis should be reconsidered. In fact, this counter intuitive concept is explained by the effect of time. Hypertension is a long-term mortality risk factor, that in a population crippled by short-acting risk factors (e.g. diabetes, congestive heart failure, malnutrition...) has not the opportunity to express itself. The clear cut noxious effect of hypertension on mortality in the years when dialysis patients were young and fit has disappeared in the present aged and highly co-morbid population. This does not mean that hypertension becomes beneficial once dialysis has been started. Hypotension is a marker of a high risk of early mortality, hypertension is a cause of late mortality. There is no evidence that hypertension might be protective in dialysis patients. Avoiding hypertension remains a capital goal of maintenance dialysis.
- 1 October 2007
- Published by JLE in Nephrologie & Therapeutique
- Vol. 3, S162-S169
L’hypertension affecte-t-elle ou non la survie des patients hémodialysés ?
Hypertension is very common in standard haemodialysis patients in spite of a wide use of antihypertensive medications. Up to the last decade it was reported in dialysis nts, as in the general population, as a powerful mortality risk factor. More recently several reports have challenged this view, and hypotension rather than hypertension has been claimed as the real culprit. That a risk factor has an opposite effect on mortality in conditions such as dialysis than in the general population has been termed - reverse epidemiology ,,, and suggests that our therapeutic approach toward blood pressure control in dialysis should be reconsidered. In fact, this counter intuitive concept is explained by the effect of time. Hypertension is a long-term mortality risk factor, that in a population crippled by short-acting risk factors (e.g. diabetes, congestive heart failure, malnutrition...) has not the opportunity to express itself. The clear cut noxious effect of hypertension on mortality in the years when dialysis patients were young and fit has disappeared in the present aged and highly co-morbid population. This does not mean that hypertension becomes beneficial once dialysis has been started. Hypotension is a marker of a high risk of early mortality, hypertension is a cause of late mortality. There is no evidence that hypertension might be protective in dialysis patients. Avoiding hypertension remains a capital goal of maintenance dialysis.
- 1 July 2007
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 68 (7) , 63-64
12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers
- 1 July 2007
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 68 (7) , 63-64
12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers
- 25 January 2007
- Published by Wiley in Hemodialysis International
- Vol. 11 (1) , 21-31
Fluid balance, dry weight, and blood pressure in dialysis
The total amount of sodium present in the body controls the extracellular volume. In advanced renal failure, sodium balance becomes positive and the extracellular volume expands. This leads to hypertension, and vascular changes that lead to adverse cardiovascular consequences in dialysis patients. Controlling the body sodium content and the extracellular volume allows one to better control hypertension and its consequences. This can be achieved by reducing the sodium input (sodium dietary restriction and reasonably low sodium dialysate) and/or by increasing the sodium output (ultrafiltration by convection). The discontinuous nature of hemodialysis causes saw‐tooth volume fluctuations. This has led to the concept of dry weight (DW), a crucial component of dialysis adequacy. Assessment and achievement of DW is feasible on pure clinical grounds. But its relative lack of accuracy (and the physicians' progressive lack of interest in bedside examination) has led to several nonclinical methods of assessing DW in an effort to improve the assessment of fluid status in dialysis patients.
- 25 January 2007
- Published by Wiley in Hemodialysis International
- Vol. 11 (1) , 21-31
Fluid balance, dry weight, and blood pressure in dialysis
The total amount of sodium present in the body controls the extracellular volume. In advanced renal failure, sodium balance becomes positive and the extracellular volume expands. This leads to hypertension, and vascular changes that lead to adverse cardiovascular consequences in dialysis patients. Controlling the body sodium content and the extracellular volume allows one to better control hypertension and its consequences. This can be achieved by reducing the sodium input (sodium dietary restriction and reasonably low sodium dialysate) and/or by increasing the sodium output (ultrafiltration by convection). The discontinuous nature of hemodialysis causes saw‐tooth volume fluctuations. This has led to the concept of dry weight (DW), a crucial component of dialysis adequacy. Assessment and achievement of DW is feasible on pure clinical grounds. But its relative lack of accuracy (and the physicians' progressive lack of interest in bedside examination) has led to several nonclinical methods of assessing DW in an effort to improve the assessment of fluid status in dialysis patients.
- 12 October 2004
- Published by Wiley in Hemodialysis International
- Vol. 8 (4) , 316-319
Dialysis overdose: Fact or reality?
- 12 October 2004
- Published by Wiley in Hemodialysis International
- Vol. 8 (4) , 316-319
Dialysis overdose: Fact or reality?
- 1 September 2004
- Vol. 56 (3) , 205-13
Role of sodium in dialysis.
The total amount of sodium present in the body conditions the extracellular compartment volume. In advanced renal failure and in dialysis the sodium balance becomes positive and the extracellular volume inflates. This leads to hypertension and to direct cardiac and vascular changes that explain for a large part the excessive cardiovascular morbidity and mortality in dialysis patients. Controlling body sodium content and extracellular volume allows to reduce hypertension, cardiovascular changes and to improve dialysis patients survival. This can be achieved by reducing the sodium input (low sodium diet and reasonably low sodium dialysate) and/or by increasing sodium output (ultrafiltration by convection in hemodialysis or hemofiltration and osmotic drive in peritoneal dialysis). The intermittent nature of hemodialysis (and hemofiltration) conditions the saw-tooth volume fluctuations that drove to conceiving and implementing the concept of a dry weight, corresponding to normal extracellular volume and blood pressure.
- 1 September 2004
- Vol. 56 (3) , 205-13
Role of sodium in dialysis.
The total amount of sodium present in the body conditions the extracellular compartment volume. In advanced renal failure and in dialysis the sodium balance becomes positive and the extracellular volume inflates. This leads to hypertension and to direct cardiac and vascular changes that explain for a large part the excessive cardiovascular morbidity and mortality in dialysis patients. Controlling body sodium content and extracellular volume allows to reduce hypertension, cardiovascular changes and to improve dialysis patients survival. This can be achieved by reducing the sodium input (low sodium diet and reasonably low sodium dialysate) and/or by increasing sodium output (ultrafiltration by convection in hemodialysis or hemofiltration and osmotic drive in peritoneal dialysis). The intermittent nature of hemodialysis (and hemofiltration) conditions the saw-tooth volume fluctuations that drove to conceiving and implementing the concept of a dry weight, corresponding to normal extracellular volume and blood pressure.
- Open Access
- 1 September 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (9) , 815
The Effect of Salt on Hypertension Control in ESRD
- 1 September 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (9) , 815
Open AccessThe Effect of Salt on Hypertension Control in ESRD
- Open Access
- 1 April 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (4) , 265-283
Long Thrice Weekly Hemodialysis: The Tassin Experience
- 1 April 2004
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 27 (4) , 265-283
Open AccessLong Thrice Weekly Hemodialysis: The Tassin Experience
- 23 January 2004
- Published by Wiley in Hemodialysis International
- Vol. 8 (1) , 51-60
Intensive dialysis and blood pressure control: A review
The prevalence of hypertension in hemodialysis (HD) patients has increased over the years. In the early days of maintenance HD blood pressure (BP) control was achieved in most patients. As sessions were shortened, the prevalence of hypertension increased. Yet, in principle, dialysis is able to control hypertension. Today, in programs using long HD, most patients are normotensive without antihypertensive medication. The same is true for patients on daily dialysis, but not for those on short thrice‐weekly HD. In all studies reporting BP normalization, dry weight is regularly achieved. Why the poor control of hypertension now? At first sight the shortened session duration is the culprit. This is suggested by several epidemiologic observations and strongly supported by a prospective experience of changing the HD schedule (short to long HD or conversely) in the same group of patients. Recent studies, however, using strict volume control show that BP normalization can be obtained in conventional 3 x 4 hr/week dialysis with relatively low delivered Kt/Vurea. Therefore, prolonging the dialysis time and/or increasing the dialysis dose are not required to achieve BP control. Intensive dialysis most probably normalizes BP by getting the extracellular volume and the amount of sodium in the body back to normal. It acts in conjunction with a moderate dietary sodium restriction and the use of reasonably low dialysate sodium. With this approach improved BP control can be achieved in the vast majority of HD patients.
- 23 January 2004
- Published by Wiley in Hemodialysis International
- Vol. 8 (1) , 51-60
Intensive dialysis and blood pressure control: A review
The prevalence of hypertension in hemodialysis (HD) patients has increased over the years. In the early days of maintenance HD blood pressure (BP) control was achieved in most patients. As sessions were shortened, the prevalence of hypertension increased. Yet, in principle, dialysis is able to control hypertension. Today, in programs using long HD, most patients are normotensive without antihypertensive medication. The same is true for patients on daily dialysis, but not for those on short thrice‐weekly HD. In all studies reporting BP normalization, dry weight is regularly achieved. Why the poor control of hypertension now? At first sight the shortened session duration is the culprit. This is suggested by several epidemiologic observations and strongly supported by a prospective experience of changing the HD schedule (short to long HD or conversely) in the same group of patients. Recent studies, however, using strict volume control show that BP normalization can be obtained in conventional 3 x 4 hr/week dialysis with relatively low delivered Kt/Vurea. Therefore, prolonging the dialysis time and/or increasing the dialysis dose are not required to achieve BP control. Intensive dialysis most probably normalizes BP by getting the extracellular volume and the amount of sodium in the body back to normal. It acts in conjunction with a moderate dietary sodium restriction and the use of reasonably low dialysate sodium. With this approach improved BP control can be achieved in the vast majority of HD patients.
- 1 January 2004
- Vol. 25 (3) , 77-81
[The peritoneal dialysis and hemodialysis studies--will they revolutionize our ways of prescribing and evaluating dialysis?].
- 1 January 2004
- Vol. 25 (3) , 77-81
[The peritoneal dialysis and hemodialysis studies--will they revolutionize our ways of prescribing and evaluating dialysis?].
- 9 October 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (4) , 342-347
The Neglect of Sodium Restriction in Dialysis Patients: A Short Review
- 9 October 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (4) , 342-347
The Neglect of Sodium Restriction in Dialysis Patients: A Short Review